A Validated Stability – Indicating Liquid Chromatographic Method for Secnidazole
DOI:
https://doi.org/10.56511/JIPBS.2015.v2.i01.pp45-52Abstract
The research work describes development of stability – indicating reverse phase – HPLC method for Secnidazole in the presence of its degradation products, generated from forced degradation studies. Secnidazole was subjected to forced degradation under acidic, basic, photolytic and oxidative conditions. Successful separation of drug from degradation products formed under forced degradation was achieved on a C 18 column (250 mm × 4.6 mm, 5 mcm) using methanol : water (60 : 40 v/v) as a mobile phase at a flow rate of 1mL/min. The detection was carried out at 310 nm. The method was validated for linearity, range, accuracy and precision.The developed method can be used to evaluate quality of regular production samples and also to test stability samples of secnidazole tablets. The intra and inter day results at each level were subjected to one way ANOVA and F values at each level were obtained as a ratio of between mean square and within mean square. The F values were found to be within limits. And the t-test value was obtained as 1.9725.
Keywords:
Secnidazole, Secnidazole tablets, HPLC, forced degradation studies, method validation.Downloads
References
International Conference of Harmonization. Stability Testing of New Drug Substances and Products, Q1A (R2). International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. IFPMA, 2003, Geneva.
Singh S, Bakshi M. Development of validated stability-indicating assay Result 4.325 2 - 14 0.998 1.21 9595.90 Table 4: Determinations of active ingredients in formulation Amount Found %Labeled Claim (mg/ml) 1015.7 101.5 990.7 99.0 995.3 99.5 methods – critical review. J Pharm Biomed Anal. 2002; 28(6): 1011.
Bolton S, Bon C. Pharmaceutical Statistics Practical and Clinical Application In: Optimization techniques and screening designs. 4th ed. Marcel Dekker, Inc; 2005:218 – 219.
M. Bakshi, B. Singh, A. Singh and S. Singh. The ICH guidance in practice: stress degradation studies on ornidazole and development of a validated stabilityindicating assay. J. Pharm. Biomed. Anal.,2001, 26(6): 891.
A.A. Moustafa, L.I. Bibawy, Stability indicating assay of Secnidizole in the presence of its degradation products. Spectroscopy letters. 32(6) (1999) 1073 – 1098.
S. Sonawane and P. Gide, Optimization of forced degradation using experimental design and development of stability indicating liquid chromatographic assay method for rebamipide in bulk and tablet dosages form. Scientia Pharmaceutical, 79, (2011) 85-96.
E. Swartz and S. Krull, Analytical method development and validation, New York (1997) 25-26.
K. G. Patel and S. J Rajput, Estimation of secnidazole and lansoprozole in pharmaceutical dosage formulation using differential spectrophotometry, East. Pharm. 41(487), (1998) 115-117.
H. D. Revanasiddappa, P. G. Ramappa and B. Manju, Spectrophotometric determination of secnidazole in pharmaceutical formulations, East. Pharm. 43, (2000) 141-145.
El Wallily AF, Abdine HH, Razak OA, Zamel S.Spectrophotometric and HPLC determination of secnidazole in pharmaceutical tablets. J Pharm Biomed Anal 2000; 22: 887-897.
S. J Rajput and K. G. Patel, Determination of secnidazole and lansoprozole in pharmaceutical dosage formulation using differential spectrophotometry, East. Pharm. 44, (2001) 129-130.
J. Lichtig, R. F. Andrade, J. M. Vaz, Determination of secnidazole in pharmaceutical table. [ Inst. Quim; Univ . Sao Paulo, 05599-070 Sao Paulo, Brazil]. Anal Chem. Acta, 332 [2-3], Vol. [58], (1996) 161-164.
Y. Patel, U.J. Dhorda, M. Sundaresan, A.M. Bhagwat, Anal. Chim. Acta 362 (1998) 271 – 277.
G.S. Sadana, M.V. Gaonkar, Indian Drugs 25 (1987) 121 – 124.
International Conference of Harmonization.Validation of Analytical Procedures: Text And Methodology, Q1A (R1).International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. IFPMA, 2005, Geneva.
Published
How to Cite
Issue
Section
Copyright (c) 2015 Priyanka P. Suryawanshi, Pathan Azhar Khan, Manadar Abhyankar, Sandeep S. Sonawane, Paraag Gide
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at